8^th International Eye and Vision Congress

Artificial Intelligence (AI) has revolutionized ophthalmology by enabling early detection of eye diseases and personalized treatment plans. This track will focus on the integration of AI in diagnostics, retinal imaging, and patient monitoring, emphasizing real-world applications and ethical considerations.

• AI-based screening for diabetic retinopathy and macular degeneration.
• Predictive analysis for disease progression.
• Ethical challenges in AI implementation.

Regenerative medicine and stem cell therapy offer promising solutions for vision restoration. This session will highlight the latest breakthroughs in using stem cells to treat retinal degeneration and corneal damage, along with their potential for clinical translation.

• Current research in stem cell-based therapies.
• Clinical trials for retinal and corneal regeneration.
• Challenges in integrating regenerative medicine into mainstream practice.

Understanding the genetic and molecular basis of eye diseases opens new doors for targeted therapies. This track will discuss gene editing tools like CRISPR, molecular mechanisms of ocular diseases, and the development of gene therapies.

• Gene therapy for inherited retinal disorders.
• Role of molecular biomarkers in early diagnosis.
• Emerging treatments based on genetic profiling.

Vision care extends beyond medical treatments to include rehabilitation and quality-of-life improvements for individuals with visual impairments. This session will cover advancements in vision prosthetics, assistive technologies, and rehabilitation techniques.

• Developments in vision prosthetics (bionic eyes).
• Rehabilitation strategies for low vision patients.
• Technology-driven assistive devices for better vision care.

Drug development for eye diseases is progressing rapidly, with novel formulations and delivery methods offering enhanced efficacy. This track will delve into emerging drugs for conditions like glaucoma and innovative delivery systems such as nanoparticles and sustained-release implants.

• Advances in glaucoma pharmacotherapy.
• Nanotechnology in ocular drug delivery.
• Challenges in clinical trials for ophthalmic drugs.

Pediatric eye health is critical for lifelong vision. This session will address early detection, genetic disorders, and new treatments for common childhood eye conditions like amblyopia and congenital cataracts.

• Innovations in diagnosing and treating amblyopia.
• Genetic insights into pediatric eye disorders.
• Importance of early intervention and preventive care.

Age-related eye diseases, such as macular degeneration and cataracts, pose significant health challenges. This track will cover prevention, diagnosis, and management strategies for these conditions, with a focus on the aging population.

• Emerging therapies for macular degeneration.
• Innovations in cataract surgery and lens implants.
• Addressing vision challenges in the elderly.

Advanced imaging technologies are reshaping how eye diseases are diagnosed and managed. This session will discuss breakthroughs in retinal imaging, optical coherence tomography (OCT), and AI-powered diagnostic tools.

• Enhanced imaging techniques for retinal diseases.
• Applications of OCT angiography in clinical practice.
• AI-driven imaging solutions.

Vision impairment and blindness disproportionately affect underserved populations. This session will focus on international efforts to improve eye health, including collaborative programs and technological innovations to address global disparities.

• Strategies for reducing blindness in low-income regions.
• Mobile health technologies for rural eye care.
• Partnerships in global eye health programs.

Neuro-ophthalmology bridges the gap between neurology and ophthalmology, addressing vision problems linked to neurological disorders. This track will explore the latest diagnostic and therapeutic approaches for conditions like optic neuritis and visual field defects.

• Understanding the brain-eye connection.
• Innovations in managing neuro-ophthalmic disorders.
• Role of imaging in neuro-ophthalmology.

The rapid pace of innovation brings ethical and regulatory considerations. This session will examine challenges in clinical trials, data privacy in AI-driven tools, and the ethical implications of genetic and stem cell therapies.

• Ethical considerations in AI and gene editing.
• Regulatory hurdles in ophthalmic drug approvals.
• Balancing innovation with patient safety.

Contact lenses and refractive surgeries have advanced significantly, offering improved vision correction and comfort. This track will explore the development of smart lenses, advanced materials, and the future of refractive error management.

• Innovations in soft and rigid gas-permeable lenses.
• Smart contact lenses for health monitoring.
• Advances in LASIK and other refractive surgery techniques.

Ocular oncology focuses on the diagnosis and treatment of eye cancers, including retinoblastoma and ocular melanoma. This session will highlight advances in imaging, targeted therapies, and the impact of genetics in managing these conditions.

• Diagnostic imaging techniques for ocular tumors.
• Targeted therapies for retinoblastoma and melanoma.
• Advances in minimally invasive treatment options.

Disorders affecting the cornea and ocular surface can severely impair vision. This session will delve into the latest research and therapies for conditions like dry eye syndrome, keratoconus, and corneal dystrophies.

• Developments in corneal transplantation techniques.
• Treatment strategies for dry eye and ocular surface diseases.
• Innovations in cross-linking for keratoconus management.